AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Total Assets 2019–2025
AbCellera Biologics Inc. annual total assets history from 2020 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- AbCellera Biologics Inc. total assets as of December 31, 2025: 1.36B, a 0.26% decrease year-over-year.
- AbCellera Biologics Inc. total assets for 2025 were 1.36B, a 0.26% decrease from 2024.
- AbCellera Biologics Inc. total assets for 2024 were 1.36B, a 8.57% decrease from 2023.
- AbCellera Biologics Inc. total assets for 2023 were 1.49B, a 3.43% decrease from 2022.
- AbCellera Biologics Inc. total assets for 2022 were 1.54B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AbCellera Biologics Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $1,357 |
| 2024 | $1,361 |
| 2023 | $1,488 |
| 2022 | $1,541 |
| 2021 | $1,319 |
| 2020 | $1,006 |
AbCellera Biologics Inc. Total Assets — FAQ
AbCellera Biologics Inc. (ABCL) total assets over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's total assets history?
The chart and table above show AbCellera Biologics Inc.'s total assets by year and by quarter, including the growth rate.